NO905090L - INTERLEUKIN-1 INHIBITORS AND PROCEDURES FOR THEIR PREPARATION. - Google Patents

INTERLEUKIN-1 INHIBITORS AND PROCEDURES FOR THEIR PREPARATION.

Info

Publication number
NO905090L
NO905090L NO90905090A NO905090A NO905090L NO 905090 L NO905090 L NO 905090L NO 90905090 A NO90905090 A NO 90905090A NO 905090 A NO905090 A NO 905090A NO 905090 L NO905090 L NO 905090L
Authority
NO
Norway
Prior art keywords
interleukin
inhibitors
procedures
preparation
Prior art date
Application number
NO90905090A
Other languages
Norwegian (no)
Other versions
NO905090D0 (en
NO316122B1 (en
Inventor
Charles H Hannun
Stephen P Eisenberg
Robert C Thompson
William P Arend
Fenneke G Joslin
Andreas Sommer
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of NO905090D0 publication Critical patent/NO905090D0/en
Publication of NO905090L publication Critical patent/NO905090L/en
Publication of NO316122B1 publication Critical patent/NO316122B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19905090A 1988-05-27 1990-11-23 DNA sequence encoding interleukin-1 inhibitors, recombinant vector containing and capable of encoding the DNA sequence, host cell containing and can express vectors, and method for producing interleukin-1 inhibitors, and recombinant host cell s. NO316122B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US19991588A 1988-05-27 1988-05-27
US23871388A 1988-08-31 1988-08-31
US26653188A 1988-11-03 1988-11-03
PCT/US1989/002275 WO1989011540A1 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors

Publications (3)

Publication Number Publication Date
NO905090D0 NO905090D0 (en) 1990-11-23
NO905090L true NO905090L (en) 1991-01-28
NO316122B1 NO316122B1 (en) 2003-12-15

Family

ID=27394086

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19905090A NO316122B1 (en) 1988-05-27 1990-11-23 DNA sequence encoding interleukin-1 inhibitors, recombinant vector containing and capable of encoding the DNA sequence, host cell containing and can express vectors, and method for producing interleukin-1 inhibitors, and recombinant host cell s.
NO20014783A NO316917B1 (en) 1988-05-27 2001-10-01 Process for the preparation of a pharmaceutical composition containing an interleukin-1 inhibitor

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20014783A NO316917B1 (en) 1988-05-27 2001-10-01 Process for the preparation of a pharmaceutical composition containing an interleukin-1 inhibitor

Country Status (9)

Country Link
JP (2) JP3192651B2 (en)
KR (1) KR970002917B1 (en)
BR (1) BR8907457A (en)
DK (1) DK172763B1 (en)
FI (2) FI109206B (en)
HU (3) HU9803037D0 (en)
NO (2) NO316122B1 (en)
OA (1) OA09631A (en)
WO (1) WO1989011540A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
ATE178094T1 (en) * 1990-05-01 1999-04-15 Chiron Corp INTERLEUKIN-I ANTAGONIST AND ITS USE
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
US5747444A (en) * 1990-10-09 1998-05-05 Chiron Corporation Method of treating graft-versus-host disease
US5932537A (en) * 1990-10-09 1999-08-03 Chiron Corporation Method for attenuating a cellular response to IL-1
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
US20060067938A1 (en) * 2001-10-26 2006-03-30 Sherif Daouti Methods for the treatment of osteoarthritis and compositions thereof
JP4761710B2 (en) 2002-04-05 2011-08-31 アムジェン インコーポレイテッド Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
EP2336177A1 (en) 2004-08-04 2011-06-22 Amgen, Inc Antibodies to DKK-1
WO2009026303A1 (en) 2007-08-21 2009-02-26 Amgen Inc. Human c-fms antigen binding proteins
CN102209557A (en) * 2008-09-12 2011-10-05 埃克斯生物科技公司 Targeting pathogenic monocytes
WO2012025910A1 (en) 2010-08-26 2012-03-01 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS AT EARLY STAGES USING INTERLEUKIN IL-1ß AS EARLY BIOMARKER OF THE DISEASE
US9359405B2 (en) 2011-03-14 2016-06-07 Phlogo Aps Antagonists of the interleukin-1 receptor
AU2012242666A1 (en) 2011-04-15 2013-11-28 Merck Patent Gmbh Anti- IL-1R1 inhibitors for use in cancer
TW201605896A (en) 2013-08-30 2016-02-16 安美基股份有限公司 GITR antigen binding proteins
WO2015087187A1 (en) 2013-12-10 2015-06-18 Rinat Neuroscience Corp. Anti-sclerostin antibodies
KR102380150B1 (en) 2016-03-08 2022-03-29 얀센 바이오테크 인코포레이티드 GITR Antibodies, Methods, and Uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3014099B2 (en) * 1987-08-26 2000-02-28 バイオジェン インコーポレイテッド Biological materials, production of biological materials and methods of using such materials for therapy

Also Published As

Publication number Publication date
OA09631A (en) 1993-04-30
NO905090D0 (en) 1990-11-23
DK8591D0 (en) 1991-01-18
JP2001029093A (en) 2001-02-06
AU633831B2 (en) 1993-02-11
DK172763B1 (en) 1999-07-05
WO1989011540A1 (en) 1989-11-30
NO20014783D0 (en) 2001-10-01
JPH03505279A (en) 1991-11-21
NO20014783L (en) 1991-01-28
NO316122B1 (en) 2003-12-15
BR8907457A (en) 1991-04-02
FI905812A0 (en) 1990-11-26
FI109206B (en) 2002-06-14
DK8591A (en) 1991-01-18
HU222810B1 (en) 2003-11-28
NO316917B1 (en) 2004-06-21
HU893412D0 (en) 1991-05-28
HU9803037D0 (en) 1999-11-29
JP3192651B2 (en) 2001-07-30
AU3746989A (en) 1989-12-12
HU215434B (en) 1999-04-28
FI20020545A (en) 2002-03-21
KR970002917B1 (en) 1997-03-12

Similar Documents

Publication Publication Date Title
NO893678L (en) CYCLOSPOR-CONTAINING PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION.
NO905090L (en) INTERLEUKIN-1 INHIBITORS AND PROCEDURES FOR THEIR PREPARATION.
DK641589A (en) N-ARYL-AZETIDINONES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS ELASTASE INHIBITORS
NO881660D0 (en) HEPARINES AND FIVE TIMES FOR THEIR PREPARATION.
DK242389A (en) HYDROXAMATE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
NO873640L (en) NEW CEFEM RELATIONS AND PROCEDURES FOR THEIR PREPARATION.
NO892745D0 (en) AMINOALKYLAMINOCARBONYLAMINODIOLAMINO ACID DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION.
NO893196D0 (en) HYBRID-PROTEIN-C COMPOSITIONS AND PROCEDURES FOR THEIR PREPARATION.
DK435588D0 (en) ARALKYLAMINOAL COXYPHENYL DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND MENTALS CONTAINING THESE
NO894624L (en) COPOLYMERS AND PROCEDURES FOR THEIR PREPARATION.
NO893886L (en) NEW AMINOQINOL COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION.
DK631587D0 (en) IMIDAZOLD DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION
DK409886D0 (en) AZOLYL-CYCLOPROPYL-ETHANOL DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE
DK530689A (en) ADENYLYCYCLASE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND THEIR USE
DK393489A (en) BENZODIAZEP RELATIONS AND PROCEDURES FOR THEIR PREPARATION
DK651087D0 (en) PURE INHIBITORS III, THEIR PREPARATION AND APPLICATION
DK360189A (en) S-ADENOSYL-METHIONIN-DECARBOXYLASE INHIBITORS, THEIR PREPARATION AND USE
NO883114L (en) 1H-PYRAZOL-1-ALKANAMIDES AND PROCEDURES FOR THEIR PREPARATION.
DK103889A (en) BENZIMIDAZOOE1,2-CAACHINAZOLINES AND PROCEDURES FOR PREPARING IT
DK251087D0 (en) DOPAMINE-BETA-HYDROLASE INHIBITORS AND PROCEDURES FOR PREPARING THEREOF
NO881777D0 (en) BENZEN SULPHONAMIDE DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION.
NO894697D0 (en) PENEME DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION.
NO893565D0 (en) ETHANSULPHONAMIDE DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION.
NO893963D0 (en) 3-ARYLOXYMETHYL-CEPHALOSPORINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF.
DK390287A (en) CEPHALOSPORINES AND DERIVATIVES THEREOF, AND PROCEDURES FOR THEIR PREPARATION

Legal Events

Date Code Title Description
LC4 Limitation of patent rights - b3 (par. 39b patent act)
MK1K Patent expired